JMP maintains Medtronic at market outperform

Medtronic, Inc. was kept at its market outperform rating by JMP Securities analyst Robert C. Faulkner. The analyst updated numbers based on changes to the ICD market growth expectations. Share assumptions for Medtronic change in 2006 to 52% from 50%; in 2007 to 52% from 50% and 2008 to 51% from 48%. Earnings per share estimates for 2007 were changed to $2.56 from $2.55, and for 2008 the estimates change to $2.96 from $2.92 to $2.96. Shares of the Minneapolis-based medical device company were up 30 cents, or 0.64%, at $47.05 on volume of 7,834,500 shares versus the three-month running average of 9,066,440 shares. (NYSE: MDT)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.